Patients with type 2 diabetes mellitus and albuminuria have higher risk of heart failure,9, 10 and treatment directed at modulating the renin–angiotensin–aldosterone system (RAAS) decreases rate of hospitalization with cardiac decompensation. This evidence concerns the gene REN and diabetes mellitus.